COVID-19 pandemic Brazil's health regulator Anvisa said Bharat Biotech's Covaxin did not meet its manufacturing standards. The Brazilian government previously signed a contract to buy 20 million doses. Bharat said in a statement that they would appeal the decision. Brazil's health regulator says Bharat Biotech’s vaccine does not meet factory standards | The Rio Times © The Rio Times Sources: The Rio Times
